Home » Headlines » Currently Reading:

Morning Headlines 2/1/17

January 31, 2017 Headlines 2 Comments

Governor McAuliffe Announces Grant to Help Doctors Identify Potential Opioid Abuse

Virginia Governor Terry McAuliffe announces that the state has received a $3.1 million grant from OxyContin manufacturer Purdue Pharma to help it integrate its prescription monitoring program with the EHRs of local providers.

King’s College Hospital London Selects Cerner’s Clinical and Financial Management System

In England, King’s College Hospital NHS Foundation Trust selects Cerner as the EHR vendor for the 100-bed hospital it is building in Dubai.

After meeting with pharma lobbyists, Trump drops promise to negotiate drug prices

Vox reports that pharmaceutical executives have persuaded President Trump to drop his call for Medicare to begin negotiating lower drug prices, opting instead for a plan that includes lowering drug company taxes and reducing regulations.

Beth Israel, Lahey health systems agree to pursue merger

In Massachusetts, Lahey Health and Beth Israel Deaconess Medical Center announce merger plans. The combined organization would include eight hospitals, 29,000 employees, and $4.5 billion in annual revenue.



HIStalk Featured Sponsors

     

Currently there are "2 comments" on this Article:

  1. Dislike – you shouldn’t dislike the Morning Headlines (or like for that matter). Say what you dislike or like. There is no nobility in poverty of a true opinion anymore.

Text Ads


RECENT COMMENTS

  1. "HHS OIG rates HHS’s information security program as “not effective” in its annual review, the same rating it gave HHS…

  2. Do these Nordic Healthcare systems concentrate the risk of a new system more that would certainly happen in the more…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.